Novartis shareholders approve all resolutions proposed by Novartis Board of Directors

Novartis shareholders approve all resolutions proposed by Novartis Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Shareholders approve 18th consecutive dividend increase to CHF 2.60 (+6%) per share for 2014  Dr. Joerg Reinhardt confirmed by shareholders as Chairman of the Novartis Board of Directors as well as all other members who have stood for annual re-election; Dr. Nancy Andrews elected as new member to the Board of Directors   Shareholders approve revisions to the Articles of Incorporation of Novartis AG for full implementation of the Swiss rules relating to the Minder Ordinance  Shareholders approve all proposals of the Novartis Board of Directors, including the 2014 compensation report as well as future Board and ECN compensation Basel, February 27, 2015 - More than 98% of Novartis shareholders today followed the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting. A total of 1,703 shareholders were present at the meeting held in Basel, representing approximately 61.1% of the issued shares of Novartis. Shareholders approved the eighteenth consecutive dividend increase per See full press release